METHOD OF RADIATION THERAPY OF PATIENTS WITH RECURRENT PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY WITH METASTASES IN REGIONAL AND RETROPERITONEAL LYMPH NODES
2019-03-15
专利权人BLOKHIN ONCOLOGY NAT MEDICAL RES CENT (BLOK-Non-standard)
申请日期2019-03-15
专利号RU2711620-C1
成果简介NOVELTY - Invention refers to medicine, namely to radiation therapy. Method of radiation therapy for patients with recurrent prostate cancer following radical prostatectomy with metastases in regional and retroperitoneal lymph nodes involves conducting a three-dimensional conformal radiation therapy in a mode of hypofractionation, using a radiation therapy with intensity modulation with dynamic arches by the principle of "simultaneous integrated boost", characterized by the simultaneous radiation exposure on regional pelvic lymph nodes: common, external and internal iliac, presacral, constrictive; lymphatic; retroperitoneal cavities with a single basic dose of 1.8Gy daily, 5 times a week, 26 fractions in total pre-total dose 46.8Gy, bed of a distant prostate and a lymphogenic recurrence zone with a single basic dose of 2.35Gy daily, 5 times a week, for 26 fractions to a total focal dose of 61.1Gy, a local and lymphogenic recurrence area with a single focal dose of 2.5Gy daily, 5 times a week, for 26 fractions, to a total basic dose of 65Gy. USE - Medicine. ADVANTAGE - Presented is a method for radiation therapy of the patients with recurrent prostate cancer following radical prostatectomy with metastases in regional and retroperitoneal lymph nodes. 1 cl, 2 ex
IPC 分类号A61N-005/10
国家俄罗斯
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/23324
专题中国科学院新疆生态与地理研究所
作者单位
BLOKHIN ONCOLOGY NAT MEDICAL RES CENT (BLOK-Non-standard)
推荐引用方式
GB/T 7714
BULYCHKIN P V,TKACHEV S I,NAZARENKO A V,et al. METHOD OF RADIATION THERAPY OF PATIENTS WITH RECURRENT PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY WITH METASTASES IN REGIONAL AND RETROPERITONEAL LYMPH NODES. RU2711620-C1[P]. 2019.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。